RAYMOND JAMES & ASSOCIATES - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,333,117
-32.4%
925,776
+16.9%
0.00%
-50.0%
Q2 2023$1,972,364
-1.5%
792,114
+6.0%
0.00%0.0%
Q1 2023$2,003,061
-26.1%
747,411
+49.8%
0.00%0.0%
Q4 2022$2,709,043
-54.8%
498,903
+4.0%
0.00%
-66.7%
Q3 2022$5,991,000
+176.8%
479,635
+9.5%
0.01%
+200.0%
Q2 2022$2,164,000
-28.4%
438,156
+10.1%
0.00%
-33.3%
Q1 2022$3,024,000
+28.0%
397,879
+72.0%
0.00%
+50.0%
Q4 2021$2,362,000
+30.6%
231,315
+71.7%
0.00%0.0%
Q3 2021$1,808,000
-37.9%
134,739
+1.6%
0.00%
-33.3%
Q2 2021$2,910,000
-1.4%
132,648
-0.7%
0.00%0.0%
Q1 2021$2,950,000
+13.1%
133,520
-7.9%
0.00%0.0%
Q4 2020$2,608,000
+37.3%
144,953
-11.9%
0.00%
+50.0%
Q3 2020$1,900,000
-48.7%
164,517
+7.7%
0.00%
-60.0%
Q2 2020$3,707,000
+2889.5%
152,788
+1253.9%
0.01%
Q1 2020$124,000
-46.8%
11,285
+28.0%
0.00%
Q4 2019$233,0008,8190.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders